NUVL's three largest insider shareholders as of April 28, 2026 are James E Flynn (Director, 16.60Mn shares), James E Flynn (Director, 16.60Mn shares), James E Flynn (Director, 16.60Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| James E Flynn | - | 0 | 16,598,450 | 24 Nov, 2025 |
| Matthew Shair | - | 1,377,194 | 201,672 | 26 Nov, 2025 |
| Matthew Shair | - | 1,377,194 | 201,672 | 26 Nov, 2025 |
| Matthew Shair | - | 1,377,194 | 201,672 | 26 Nov, 2025 |
| Andrew A. F. Hack | - | 0 | 1,447,267 | 13 Dec, 2024 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | - | 897,671 | 0 | 03 Aug, 2021 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | - | 897,671 | 0 | 03 Aug, 2021 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James E Flynn | - | 0 | 650,000 | 07 Nov, 2022 |
| James Richard Porter | President And Ceo | 324,879 | 0 | 08 Apr, 2026 |
| James Richard Porter | President And Ceo | 324,879 | 0 | 10 Mar, 2026 |
| James Richard Porter | President And Ceo | 324,879 | 0 | 08 Apr, 2026 |
| Alexandra Balcom | Chief Financial Officer | 85,533 | 0 | 03 Apr, 2026 |
| Christopher Durant Turner | Chief Medical Officer | 72,630 | 0 | 07 Jan, 2026 |
| Christopher Durant Turner | Chief Medical Officer | 72,630 | 0 | 07 Jan, 2026 |
| Christopher Durant Turner | Chief Medical Officer | 72,630 | 0 | 07 Jan, 2026 |
| Henry E. Pelish | Chief Scientific Officer | 65,604 | 0 | 16 Mar, 2026 |
| Henry E. Pelish | Chief Scientific Officer | 65,604 | 0 | 16 Mar, 2026 |
| Henry E. Pelish | Chief Scientific Officer | 65,604 | 0 | 13 Apr, 2026 |
| Deborah Ann Miller | Chief Legal Officer | 59,634 | 0 | 30 Mar, 2026 |
| Darlene Noci | Chief Development Officer | 58,117 | 0 | 01 Apr, 2026 |
| Benjamin Lane | - | 50,368 | 0 | 02 Apr, 2026 |
| Grant C. Bogle | - | 5,847 | 0 | 20 Jun, 2025 |
| Joseph Pearlberg | - | 5,146 | 0 | 20 Jun, 2025 |
| Sapna Srivastava | - | 5,146 | 0 | 20 Jun, 2025 |
| Anna Protopapas | - | 5,146 | 0 | 20 Jun, 2025 |
| Michael L. Meyers | - | 5,146 | 0 | 20 Jun, 2025 |
| Joseph Pearlberg | - | 5,146 | 0 | 20 Jun, 2025 |
| Cameron Wheeler | - | 5,146 | 0 | 20 Jun, 2025 |
| Cameron Wheeler | - | 5,146 | 0 | 20 Jun, 2025 |
| Sapna Srivastava | - | 5,146 | 0 | 20 Jun, 2025 |
| Anna Protopapas | - | 5,146 | 0 | 20 Jun, 2025 |
| Joseph Pearlberg | - | 5,146 | 0 | 20 Jun, 2025 |
| Cameron Wheeler | - | 5,146 | 0 | 20 Jun, 2025 |
| Anna Protopapas | - | 5,146 | 0 | 20 Jun, 2025 |
| Christy J. Oliger | - | 3,971 | 0 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| James E Flynn | - | 0 | 2,647 | 20 Jun, 2025 |
| Emily Conley | - | 2,507 | 0 | 27 Aug, 2024 |
| Andrew A. F. Hack | - | 2,499 | 0 | 14 Jun, 2024 |
| Dwight Gary Gilliland | - | 2,499 | 0 | 14 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Henry E. Pelish | Class A Common Stock | A | 3,093 | $27.85 | 68,697 | D | M |
| 09 Apr, 2026 | Henry E. Pelish | Class A Common Stock | D | 2,193 | $104.27 | 66,504 | D | S |
| 09 Apr, 2026 | Henry E. Pelish | Class A Common Stock | D | 900 | $105.00 | 65,604 | D | S |
| 09 Apr, 2026 | Henry E. Pelish | Stock Option (Right to Buy) | D | 3,093 | $0.00 | 8,309 | D | M |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | A | 13,714 | $18.93 | 338,593 | D | M |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | A | 13,714 | $18.93 | 338,593 | D | M |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | A | 16,286 | $27.85 | 354,879 | D | M |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | A | 16,286 | $27.85 | 354,879 | D | M |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 11,354 | $103.21 | 343,525 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 11,354 | $103.21 | 343,525 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 12,425 | $103.78 | 331,100 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 12,425 | $103.78 | 331,100 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 6,121 | $104.78 | 324,979 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 6,121 | $104.78 | 324,979 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 100 | $105.60 | 324,879 | D | S |
| 06 Apr, 2026 | James Richard Porter | Class A Common Stock | D | 100 | $105.60 | 324,879 | D | S |
| 06 Apr, 2026 | James Richard Porter | Stock Option (Right to Buy) | D | 13,714 | $0.00 | 208,686 | D | M |
| 06 Apr, 2026 | James Richard Porter | Stock Option (Right to Buy) | D | 13,714 | $0.00 | 208,686 | D | M |
| 06 Apr, 2026 | James Richard Porter | Stock Option (Right to Buy) | D | 16,286 | $0.00 | 131,494 | D | M |
| 06 Apr, 2026 | James Richard Porter | Stock Option (Right to Buy) | D | 16,286 | $0.00 | 131,494 | D | M |